The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Metal-NHC complexes: a survey of anti-cancer properties
Abstract
New weapons to fight cancer are constantly needed. Among chemotherapeutics, anti-cancer metal-drugs have enjoyed a long and successful history since the discovery of the benchmark cisplatin. Advances in metal-drug discovery have motivated chemists to build plethora of complex structures. Among them, a novel area is emerging. This article presents a survey of the metal-N-Heterocyclic Carbenes (Ag(I), Au(I), Pd(II) and Cu(I)-NHCs) as potential anti-cancer agents. Most of the metal-NHCs considered display higher cytotoxicities than the reference metallo-drug cisplatin. Some of them are even selective for particular cell lines. Their mechanisms of action at the cellular level are further discussed, showing that the nature of the metal is of great importance. All these promising results demonstrate that this approach deserves more attention and work.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Arduengo, A. J., Harlow, R. L., & Kline, M. (1991) · Journal of the American Chemical Society · doi:10.1021/ja00001a054 · Cited by 4,228
N-Heterocyclic Carbenes: A New Concept in Organometallic Catalysis
Herrmann, W. A. (2002) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20020415)41:8<1290::aid-anie1290>3.0.co;2-y · Cited by 3,769
Cisplatin: mode of cytotoxic action and molecular basis of resistance
Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335
Organocatalysis by N-Heterocyclic Carbenes
Enders, D., Niemeier, O., & Henseler, A. (2007) · Chemical Reviews · doi:10.1021/cr068372z · Cited by 3,059
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
Jamieson, E. R., & Lippard, S. J. (1999) · Chemical Reviews · doi:10.1021/cr980421n · Cited by 2,949
N‐Heterocyclic Carbenes as Organocatalysts
Marion, N., Díez‐González, S., & Nolan, S. P. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200603380 · Cited by 1,459
Facile Synthesis of Silver(I)−Carbene Complexes. Useful Carbene Transfer Agents
Wang, H. M. J., & Lin, I. J. B. (1998) · Organometallics · doi:10.1021/om9709704 · Cited by 1,172
Sigman, D. S., Mazumder, A., & Perrin, D. M. (1993) · Chemical Reviews · doi:10.1021/cr00022a011 · Cited by 921
1,3-Dimethyl-4-imidazolinyliden-(2)-pentacarbonylchrom ein neuer übergangsmetall-carben-komplex
Öfele, K. (1968) · Journal of Organometallic Chemistry · doi:10.1016/s0022-328x(00)88691-x · Cited by 878
Rademaker-Lakhai, J. M., van den Bongard, D., Pluim, D., Beijnen, J. H., & Schellens, J. H. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0746 · Cited by 833
Hartinger, C. G., Jakupec, M. A., Zorbas‐Seifried, S., Groessl, M., Egger, A., Berger, W., Zorbas, H., Dyson, P. J., & Keppler, B. K. (2008) · Chemistry & Biodiversity · doi:10.1002/cbdv.200890195 · Cited by 830
On the medicinal chemistry of gold complexes as anticancer drugs
Ott, I. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.019 · Cited by 825
Copper Complexes as Anticancer Agents
Marzano, C., Pellei, M., Tisato, F., & Santini, C. (2009) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152009787313837 · Cited by 802
Ray, S., Mohan, R., Singh, J. K., Samantaray, M. K., Shaikh, M. M., Panda, D., & Ghosh, P. (2007) · Journal of the American Chemical Society · doi:10.1021/ja075889z · Cited by 656
Hickey, J. L., Ruhayel, R. A., Barnard, P. J., Baker, M. V., Berners-Price, S. J., & Filipovska, A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja804027j · Cited by 599
Melaiye, A., Sun, Z., Hindi, K., Milsted, A., Ely, D., Reneker, D. H., Tessier, C. A., & Youngs, W. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja040226s · Cited by 557
Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death
Herceg, Z., & Wang, Z.-Q. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00111-7 · Cited by 488
N-Heterocyclic carbene–silver complexes: A new class of antibiotics
Kascatan-Nebioglu, A., Panzner, M. J., Tessier, C. A., Cannon, C. L., & Youngs, W. J. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2006.08.019 · Cited by 479
Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death
Duriez, P., & Shah, G. M. (1997) · Biochemistry and Cell Biology · doi:10.1139/o97-043 · Cited by 418
Targeting the mitochondrial cell death pathway with gold compounds
Barnard, P. J., & Berners-Price, S. J. (2007) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2007.04.006 · Cited by 417
(NHC)Copper(I)‐Catalyzed [3+2] Cycloaddition of Azides and Mono‐ or Disubstituted Alkynes
Díez‐González, S., Correa, A., Cavallo, L., & Nolan, S. P. (2006) · Chemistry – A European Journal · doi:10.1002/chem.200600961 · Cited by 370
Formation of Water-Soluble Pincer Silver(I)−Carbene Complexes: A Novel Antimicrobial Agent
Melaiye, A., Simons, R. S., Milsted, A., Pingitore, F., Wesdemiotis, C., Tessier, C. A., & Youngs, W. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030262m · Cited by 349
Hannon, M. J. (2007) · Pure and Applied Chemistry · doi:10.1351/pac200779122243 · Cited by 313
Barnard, P. J., Wedlock, L. E., Baker, M. V., Berners‐Price, S. J., Joyce, D. A., Skelton, B. W., & Steer, J. H. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200601526 · Cited by 260
Cell cycle control in breast cancer cells
Caldon, C. E., Daly, R. J., Sutherland, R. L., & Musgrove, E. A. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20690 · Cited by 238
Hindi, K. M., Siciliano, T. J., Durmus, S., Panzner, M. J., Medvetz, D. A., Reddy, D. V., Hogue, L. A., Hovis, C. E., Hilliard, J. K., Mallet, R. J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm0708679 · Cited by 218
Vessières, A., Top, S., Beck, W., Hillard, E., & Jaouen, G. (2006) · Dalton Trans. · doi:10.1039/b509984f · Cited by 180
Anti-cancer potential of gold complexes
Tiekink, E. R. T. (2008) · Inflammopharmacology · doi:10.1007/s10787-007-0018-5 · Cited by 166
Copper-dependent cleavage of DNA by bleomycin
Ehrenfeld, G. M., Shipley, J. B., Heimbrook, D. C., Sugiyama, H., Long, E. C., BOOM, J. H. V., van der MAREL, G. A., Oppenheimer, N. J., & Hecht, S. M. (1987) · Biochemistry · doi:10.1021/bi00377a038 · Cited by 156
Gold(I)-Mediated Inhibition of Protein Tyrosine Phosphatases: A Detailed in Vitro and Cellular Study
Krishnamurthy, D., Karver, M. R., Fiorillo, E., Orrù, V., Stanford, S. M., Bottini, N., & Barrios, A. M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800101w · Cited by 127
p53-A natural cancer killer: Structural insights and therapeutic concepts
Römer, L., Klein, C., Dehner, A., Kessler, H., & Buchner, J. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600611 · Cited by 93
Cited by
Advances in Copper Complexes as Anticancer Agents
Santini, C., Pellei, M., Gandin, V., Porchia, M., Tisato, F., & Marzano, C. (2014) · Chemical Reviews · doi:10.1021/cr400135x · Cited by 1,790
Organometallic Anticancer Compounds
Gasser, G., Ott, I., & Metzler-Nolte, N. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100020w · Cited by 1,624
Stable Cyclic Carbenes and Related Species beyond Diaminocarbenes
Melaimi, M., Soleilhavoup, M., & Bertrand, G. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201000165 · Cited by 1,066
Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs
Liu, W., & Gust, R. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35314h · Cited by 762
N-Heterocyclic carbene metal complexes in medicinal chemistry
Oehninger, L., Rubbiani, R., & Ott, I. (2013) · Dalton Trans. · doi:10.1039/c2dt32617e · Cited by 560
Metadata
- Authors
- Teyssot, M.-L., Jarrousse, A.-S., Manin, M., Chevry, A., Roche, S., Norre, F., Beaudoin, C., Morel, L., Boyer, D., Mahiou, R., & Gautier, A.
- Venue
- Dalton Transactions
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2009
- Issue
- 35
- Pages
- 6894
- ISSN
- 1477-9226 (ISSN-L)
- 1477-9234
- OpenAlex
- W2093345655
- Cited by
- 384
- References
- 33
- FWCI
- 13.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.